Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,142 Cr
up ₹251 Cr vs Mar 2026
- Stocks held
- 30
- unchanged
- Top 10 weight
- 65.4%
- of the portfolio in its ten largest
- Cash & debt
- 2.4%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 4
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In April 2026 it disclosed 30 stocks worth ₹3,142 Cr, up ₹251 Cr from Mar 2026. Its largest positions were Sun Pharmaceutical Industries Limited (8.8%), IPCA Laboratories Limited (8.3%), Cipla Limited (7.6%); the ten largest together made up 65.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 63.9% of its equity. Cash and debt stood at 2.4%. Compared with Mar 2026 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
91%
Top-10 weight is higher than 91% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
34%
Holds more cash than 34% of peers
Holdings in April 2026
Download CSVEvery line the fund disclosed, with the change against Mar 2026. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.84%
- Δ weight
- down 0.49 pts
- Value
- ₹278 Cr
- Δ value
- up ₹7.8 Cr
- Status
- Added
- Weight
- 8.26%
- Δ weight
- down 1.13 pts
- Value
- ₹260 Cr
- Δ value
- down ₹11.9 Cr
- Status
- Trimmed
- Weight
- 7.56%
- Δ weight
- down 0.12 pts
- Value
- ₹237 Cr
- Δ value
- up ₹15.5 Cr
- Status
- Added
- Weight
- 7.35%
- Δ weight
- down 0.23 pts
- Value
- ₹231 Cr
- Δ value
- up ₹11.7 Cr
- Status
- Added
- Weight
- 6.42%
- Δ weight
- up 0.13 pts
- Value
- ₹202 Cr
- Δ value
- up ₹19.8 Cr
- Status
- Added
- Weight
- 6.16%
- Δ weight
- down 0.31 pts
- Value
- ₹194 Cr
- Δ value
- up ₹6.5 Cr
- Status
- Added
- Weight
- 6.10%
- Δ weight
- up 0.08 pts
- Value
- ₹192 Cr
- Δ value
- up ₹17.5 Cr
- Status
- Added
- Weight
- 5.13%
- Δ weight
- down 0.27 pts
- Value
- ₹161 Cr
- Δ value
- up ₹5 Cr
- Status
- Added
- Weight
- 4.83%
- Δ weight
- up 1.73 pts
- Value
- ₹152 Cr
- Δ value
- up ₹62.2 Cr
- Status
- Added
- Weight
- 4.73%
- Δ weight
- down 0.26 pts
- Value
- ₹149 Cr
- Δ value
- up ₹4.2 Cr
- Status
- Added
- Weight
- 3.43%
- Δ weight
- up 0.16 pts
- Value
- ₹108 Cr
- Δ value
- up ₹13.1 Cr
- Status
- Added
- Weight
- 3.36%
- Δ weight
- up 0.58 pts
- Value
- ₹106 Cr
- Δ value
- up ₹25.1 Cr
- Status
- Added
- Weight
- 3.01%
- Δ weight
- down 0.27 pts
- Value
- ₹94.5 Cr
- Δ value
- down ₹20 L
- Status
- Held
- Weight
- 2.97%
- Δ weight
- up 0.10 pts
- Value
- ₹93.4 Cr
- Δ value
- up ₹10.5 Cr
- Status
- Added
- Weight
- 2.64%
- Δ weight
- up <0.01 pts
- Value
- ₹83.1 Cr
- Δ value
- up ₹6.7 Cr
- Status
- Added
- Weight
- 2.60%
- Δ weight
- down 0.23 pts
- Value
- ₹81.8 Cr
- Δ value
- down ₹10 L
- Status
- Held
- Cash, TREPS & receivables
- Weight
- 2.39%
- Δ weight
- up 0.94 pts
- Value
- ₹75.2 Cr
- Δ value
- up ₹33.2 Cr
- Status
- Added
- Weight
- 2.16%
- Δ weight
- up 0.32 pts
- Value
- ₹67.7 Cr
- Δ value
- up ₹14.7 Cr
- Status
- Added
- Weight
- 2.01%
- Δ weight
- down 0.13 pts
- Value
- ₹63.3 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 1.81%
- Δ weight
- up 0.06 pts
- Value
- ₹56.7 Cr
- Δ value
- up ₹6.1 Cr
- Status
- Added
- Weight
- 1.35%
- Δ weight
- down 0.07 pts
- Value
- ₹42.6 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 1.07%
- Δ weight
- down 0.04 pts
- Value
- ₹33.6 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 1.06%
- Δ weight
- up 0.19 pts
- Value
- ₹33.2 Cr
- Δ value
- up ₹8.2 Cr
- Status
- Added
- Weight
- 1.02%
- Δ weight
- up 0.08 pts
- Value
- ₹32.1 Cr
- Δ value
- up ₹4.8 Cr
- Status
- Added
- Weight
- 0.87%
- Δ weight
- down 0.19 pts
- Value
- ₹27.3 Cr
- Δ value
- down ₹3.4 Cr
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.84%
- Δ weight
- down 0.04 pts
- Value
- ₹26.4 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 0.64%
- Δ weight
- down 0.04 pts
- Value
- ₹20.2 Cr
- Δ value
- up ₹38 L
- Status
- Added
- Weight
- 0.53%
- Δ weight
- down 0.02 pts
- Value
- ₹16.8 Cr
- Δ value
- up ₹62 L
- Status
- Added
- Weight
- 0.37%
- Δ weight
- down 0.05 pts
- Value
- ₹11.5 Cr
- Δ value
- down ₹52 L
- Status
- Trimmed
- Weight
- 0.18%
- Δ weight
- up 0.02 pts
- Value
- ₹5.6 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 0.15%
- Δ weight
- down 0.48 pts
- Value
- ₹4.7 Cr
- Δ value
- down ₹13.5 Cr
- Status
- Trimmed
- Weight
- 0.14%
- Δ weight
- down <0.01 pts
- Value
- ₹4.5 Cr
- Δ value
- up ₹26 L
- Status
- Added
What changed, Mar 2026 to Apr 2026
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Suven Pharmaceuticals Limitedup ₹62.2 Cr (+1.73% pts)
- Vijaya Diagnostic Centre Limitedup ₹25.1 Cr (+0.58% pts)
- Laurus Labs Limitedup ₹19.8 Cr (+0.13% pts)
- Sai Life Sciences Limitedup ₹17.5 Cr (+0.08% pts)
- Cipla Limitedup ₹15.5 Cr (−0.12% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2026, the weight rose most in Pharmaceuticals (+0.4 pts) and Healthcare Services (+0.2 pts), and fell most in Healthcare Equipment & Supplies (−0.4 pts) and Pharmaceuticals & Biotechnology (−0.1 pts).
- Pharmaceuticals3.9% → 4.2%+0.4 pts
- Healthcare Services19.3% → 19.4%+0.2 pts
- Healthcare Equipment & Supplies10.8% → 10.5%−0.4 pts
- Pharmaceuticals & Biotechnology64.0% → 63.9%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2023 | Apr 2025 | Oct 2025 | Jan 2026 | Mar 2026 | Apr 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 69.5% | 65.9% | 66.2% | 62.5% | 64.0% | 63.9% |
| Healthcare Services | 15.1% | 17.6% | 18.6% | 20.0% | 19.3% | 19.4% |
| Healthcare Equipment & Supplies | 6.4% | 8.9% | 7.9% | 10.9% | 10.8% | 10.5% |
| Pharmaceuticals | 5.7% | 5.6% | 5.4% | 4.6% | 3.9% | 4.2% |
| Insurance | 2.1% | 1.6% | 1.6% | 1.5% | 1.5% | 1.4% |
| Retailing | 1.2% | 0.5% | 0.5% | 0.5% | 0.6% | 0.6% |
Allocation in Apr 2026change vs Mar 2026
- Pharmaceuticals & Biotechnology (15)63.9%▼ 0.1 pts
- Healthcare Services (7)19.4%▲ 0.2 pts
- Healthcare Equipment & Supplies (3)10.5%▼ 0.4 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Apr 2026
2.4%
▲ 0.9 pts vs Mar 2026
- Cash alone
- 2.4%
- cash and net receivables
- A year earlier
- 0.1%
- Apr 2025 · now ▲ 2.3 pts
- Last 12 months
- 0.4% – 2.4%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.